New kidney stone tool tested – but study stopped early
NCT ID NCT06547632
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new device called ClearPetra, which uses suction to remove kidney stone fragments during surgery, against the usual approach. Only 3 adults with kidney stones were enrolled before the study was stopped. The goal was to see if the device could clear stones better and lower infection rates, but the small size means no firm conclusions can be made.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ClearPetra vacuum-assisted ureteral access sheath (device)
- What this could lead to
- If successful, this device could make kidney stone surgery faster and reduce infection risk by continuously removing stone fragments.
- What could go wrong
- The trial was terminated early with only 3 participants, so no reliable conclusions can be drawn. The device is new to the US market and more research is needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Males or females over18 years of age 2. Undergoing primary flexible ureteroscopy for retrograde intrarenal surgery 3. Total stone burden between 1.0 to 2.5 cm Exclusion Criteria: 1. Undergoing bilateral stone treatment during the same procedure 2. Patients with known genitourinary anatomical abnormalities 3. Uncorrected coagulopathy 4. Patients with urinary diversions 5. Chronic external urinary catheters 6. Women who are pregnant 7. Immunosuppressed patients 8. Non-elective procedures
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney stone are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency drainage gives the best kidney stone surgery results?
- Can a single drug dose curb opioid side effects after kidney stone surgery?
- Can a thinner scope make kidney stone surgery easier and cheaper?
- Can a One-Day catheter beat the stent for kidney stone recovery?
- Which kidney stone surgery causes more Pre-Op worry?
- A new standard for pain pills after kidney stone surgery?